Envoy Medical (Envoy Medical) EBITDA Margin % : -10,508.47% (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Envoy Medical EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Envoy Medical's EBITDA for the three months ended in Mar. 2024 was $-6.20 Mil. Envoy Medical's Revenue for the three months ended in Mar. 2024 was $0.06 Mil. Therefore, Envoy Medical's EBITDA margin for the quarter that ended in Mar. 2024 was -10,508.47%.

Envoy Medical EBITDA Margin % Historical Data

The historical data trend for Envoy Medical's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Envoy Medical EBITDA Margin % Chart

Envoy Medical Annual Data

Trend

Dec21

Dec22

Dec23

EBITDA Margin %

-2,193.55

-3,641.77

-5,771.52

Envoy Medical Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBITDA Margin %	Get a 7-Day Free Trial				-16,956.41	-7,065.08	-4,195.00	-7,038.95	-10,508.47

Competitive Comparison of Envoy Medical's EBITDA Margin %

For the Medical Devices subindustry, Envoy Medical's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Envoy Medical's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Envoy Medical's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Envoy Medical's EBITDA Margin % falls into.

Envoy Medical EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Envoy Medical's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-18.238	/	0.316
	=	-5,771.52 %

Envoy Medical's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %	=	EBITDA (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-6.2	/	0.059
	=	-10,508.47 %

Envoy Medical (NAS:COCH) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Envoy Medical EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Envoy Medical's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Envoy Medical (Envoy Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Envoy Medical Inc (NAS:COCH) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

4875 White Bear Parkway, White Bear Lake, MN, USA, 55110

Website

https://www.envoymedical.com

Envoy Medical Inc is focused on designing, developing, and marketing fully implantable medical devices that improve hearing. The Company's first commercial product, the Esteem PMA application, is a fully implantable hearing device. The Esteem PMA was cleared in 2010 by the United States Food and Drug Administration. The Company intends to continue to pursue the development of a cochlear implant.